Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

NCT00838526 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00838526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00838526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
December 31, 2009
Enrollment
240 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease (gerd)